glp-1 역할 제제에 비만 적응증을 허하다 < 내분비/신장 < 내분비/신장 < 학술 < 기사본문 주 1회 GLP-1 제제 '위고비'가
Description
I wake up with more energy
Expanding insurance coverage, rising obesity prevalence and broader physician adoption are all contributing to the rapid mainstream acceptance of these therapies
The benefit of this treatment is that it does not pose risks for rejection because it uses the patients own fat
Yes, many patients safely use both medications together
